Beneficial effects of Dendrobium officinale on metabolic hypertensive rats by triggering the enteric-origin SCFA-GPCR43/41 pathway.

Given the increasing global trend toward unhealthy lifestyles and dietary decisions, such as "over-consumption of alcohol, and high sugar and fat diets" (ACHSFDs), it is not surprising that metabolic hypertension (MH) is now the most common type of hypertension. There is an urgent, global need for effective measures for the prevention and treatment of MH. Improper diet leads to decreased short-chain fatty acid (SCFA) production in the gut, leading to decreased gastrointestinal function, metabolism, and blood pressure as a result of signaling through G-protein-coupled receptors (GPCRs), ultimately causing MH. Previous studies have suggested that Dendrobium officinale (DO) may improve gastrointestinal function, lower blood pressure, and regulate metabolic abnormalities, but it is not clear whether it acts on MH by increasing SCFA and, if so, how. In this research, it was observed that Dendrobium officinale ultrafine powder (DOFP) could lower blood pressure and improve lipid abnormalities in ACHSFD-induced MH model rats. Moreover, DOFP was found to improve the intestinal flora and increased the SCFA level in feces and serum, as well as increased the expressions of GPCR43/41 and eNOS and the nitric oxide (NO) level. An experiment on isolated aorta rings revealed that DOFP improved the vascular endothelial relaxation function in MH rats, and this effect could be blocked by the eNOS inhibitor l-NAME. These experimental results suggest that DOFP improved the intestinal flora and increased the production, transportation, and utilization of SCFA, activated the intestinal-vascular axis SCFA-GPCR43/41 pathway, improved vascular endothelial function, and finally lowered blood pressure in MH model rats. This research provides a new focus for the mechanism of the effect of DOFP against MH by triggering the enteric-origin SCFA-GPCR43/41 pathway.

[1]  S. Xiong,et al.  Hypertensive Rats Treated Chronically With Nω-Nitro-L-Arginine Methyl Ester (L-NAME) Induced Disorder of Hepatic Fatty Acid Metabolism and Intestinal Pathophysiology , 2020, Frontiers in Pharmacology.

[2]  Dongfang Su,et al.  Curcumin prevents high-fat diet-induced hepatic steatosis in ApoE−/− mice by improving intestinal barrier function and reducing endotoxin and liver TLR4/NF-κB inflammation , 2019, Nutrition & Metabolism.

[3]  Xue Chen,et al.  Dendrobii Officinalis, a traditional Chinese edible and officinal plant, accelerates liver recovery by regulating the gut-liver axis in NAFLD mice , 2019, Journal of Functional Foods.

[4]  Yi Feng,et al.  MDG-1, an Ophiopogon polysaccharide, restrains process of non-alcoholic fatty liver disease via modulating the gut-liver axis. , 2019, International journal of biological macromolecules.

[5]  Jian Liang,et al.  Protective roles and mechanisms of Dendrobium officinal polysaccharides on secondary liver injury in acute colitis. , 2018, International journal of biological macromolecules.

[6]  G. Lv,et al.  Combined Antihypertensive Effect of Paeoniflorin Enriched Extract and Metoprolol in Spontaneously Hypertensive Rats , 2018, Pharmacognosy magazine.

[7]  C. Mackay,et al.  Beyond gut feelings: how the gut microbiota regulates blood pressure , 2018, Nature Reviews Cardiology.

[8]  S. Glantz,et al.  Sugar industry sponsorship of germ-free rodent studies linking sucrose to hyperlipidemia and cancer: An historical analysis of internal documents , 2017, PLoS biology.

[9]  N. Puri,et al.  The transcriptional regulation of the human angiotensinogen gene after high-fat diet is haplotype-dependent: Novel insights into the gene-regulatory networks and implications for human hypertension , 2017, PloS one.

[10]  A. El-Osta,et al.  High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice , 2017, Circulation.

[11]  QuChao,et al.  Granularity and Laxative Effect of Ultrafine Powder of Dendrobium officinale , 2017 .

[12]  Weili Zhang,et al.  Gut microbiota dysbiosis contributes to the development of hypertension , 2017, Microbiome.

[13]  N M Delzenne,et al.  The link between inflammation, bugs, the intestine and the brain in alcohol dependence , 2017, Translational Psychiatry.

[14]  C. Pepine,et al.  Hypertension-Linked Pathophysiological Alterations in the Gut , 2017, Circulation research.

[15]  J. DiNicolantonio,et al.  Hypertension Due to Toxic White Crystals in the Diet: Should We Blame Salt or Sugar? , 2016, Progress in cardiovascular diseases.

[16]  S. Flavahan,et al.  Microbial short chain fatty acid metabolites lower blood pressure via endothelial G protein-coupled receptor 41. , 2016, Physiological genomics.

[17]  H. Itoh,et al.  The role of short-chain fatty acid on blood pressure regulation , 2016, Current opinion in nephrology and hypertension.

[18]  Daoyan Liu,et al.  The Gastrointestinal Tract: an Initial Organ of Metabolic Hypertension? , 2016, Cellular Physiology and Biochemistry.

[19]  N. Barnich,et al.  90 Western Diet Induces a Shift in Microbiota Composition Enhancing Susceptibility to Adherent-Invasive E. Coli Infection and Intestinal Inflammation , 2016 .

[20]  G. Phillips,et al.  Study on Dendrobium officinale O-Acetyl-glucomannan (Dendronan). 7. Improving Effects on Colonic Health of Mice. , 2016, Journal of agricultural and food chemistry.

[21]  A. Schutte,et al.  Alcohol intake, hypertension development and mortality in black South Africans , 2016, European journal of preventive cardiology.

[22]  C. Pepine,et al.  Gut Dysbiosis Is Linked to Hypertension , 2015, Hypertension.

[23]  Huiwen Wu,et al.  A Model of Metabolic Syndrome and Related Diseases with Intestinal Endotoxemia in Rats Fed a High Fat and High Sucrose Diet , 2014, PloS one.

[24]  A. McAinch,et al.  The therapeutic potential of GPR43: a novel role in modulating metabolic health , 2013, Cellular and Molecular Life Sciences.

[25]  J. Gordon,et al.  Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation , 2013, Proceedings of the National Academy of Sciences.

[26]  P. Pool.  The case for metabolic hypertension: is it time to restructure the hypertension paradigm? , 1993, Progress in cardiovascular diseases.